Vision
Premium drug contracting to track and improve profitability
As a leading specialty GPO, we're dedicated to maximizing contract performance for your specialty medications. Securing competitive pharmaceutical contracts on frequently prescribed therapies is what we do best. Through our extensive industry experience, expansive membership and versatile contract portfolio, we allow vision practices the ability to maximize rebates on drug contracts that is unrivaled in the industry. Your practice can share in the network’s purchasing power to reduce costs on pharmaceuticals, diagnostic testing, surgical supplies and medical equipment, while remaining an independent and autonomous entity.
Discover how a GPO membership can benefit your specialty practice by completing the form below:
Supporting your vision practice
As a GPO member, you have access to educational opportunities, advanced analytics, emerging solutions and programs, and legislative advocacy to propel your practice forward.
Advocate on behalf of your practice
We are dedicated to advocating on behalf of community practices. Through our Community Counts platform, we will advocate on the latest in legislative and reimbursement issues specialty practices are facing, differentiate community vision practices from other sites of care, and empower physicians, patients and their families to effectively communicate with legislators.
Maximize rebates and discounts with advanced analytics
Analyzing contract performance is at the core of our GPO services. Using comprehensive analytics solutions and tools, our dedicated account management team will support your practice in maximizing rebates and discounts on your purchases so you can focus on what matters most – patient care.
Enhance clinical efficiencies within your practice
As a GPO member, you have access to competitive pricing on advanced technology and services such as practice and financial analytics and MIPS consulting that can help optimize your practice’s business performance and reporting requirements, and ultimately, your bottom line.
White Paper
Biosimilar basics
Biosimilars have the potential to reduce costs and expand access to life-changing drugs in the United States. Yet many providers do not have a complete understanding or high level of confidence in the Food and Drug Administration’s (FDA) process for approving biosimilars and the biosimilar pipeline. Download our white paper to learn the basics.
Practice business analytics
Identifying claims paid below cost
Between understanding contracted pricing agreements and working with so many different payers, it's easy to see how your practice might accidentally close a drug claim without recovering the full cost of the medication. With InfoDive's Buy and Bill report, we can quickly identify closed claims where you've accepted less than your invoice cost. We'll arm you with the details you need to recover those costs and help you identify operational improvements that might have contributed to the loss in the first place.
MIPS consulting services
Ensuring the health of your practice